BAXTER INTERNATIONAL INC — Director's Dealing 2015

Jul 2, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BAXTER INTERNATIONAL INC (BAX)
CIK: 0000010456
Period of Report: 2015-06-30

Reporting Person: Eyre Brik V (CVP, Hospital Products)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $1 par value	29429	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Deferred Comp Plan Baxter Common Stock Fund	$		Common Stock, $1 par value (46)		Direct
Stock Option (Right to Buy)	$53.80	2021-03-04	Common Stock, $1 par value (4550)		Direct
Stock Option (Right to Buy)	$57.48	2022-03-06	Common Stock, $1 par value (6563)		Direct
Stock Option (Right to Buy)	$70.24	2023-03-05	Common Stock, $1 par value (19627)		Direct
Stock Option (Right to Buy)	$68.17	2023-12-02	Common Stock, $1 par value (10000)		Direct
Stock Option (Right to Buy)	$69.03	2024-03-04	Common Stock, $1 par value (42992)		Direct
Stock Option (Right to Buy)	$69.42	2025-03-03	Common Stock, $1 par value (83056)		Direct

Footnotes

F1: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan.

F2: 1 for 1

F3: This option is presently exercisable in full.

F4: Two-thirds of this option is presently exercisable. The remaining one-third becomes exercisable on March 5, 2016.

F5: One-third of this option is presently exercisable. The remaining two-thirds become exercisable on December 2, 2015 and December 2, 2016.

F6: One-third of this option is presently exercisable. The remaining two-thirds become exercisable on March 4, 2016 and March 4, 2017.

F7: This option will vest in three equal annual installments beginning on March 3, 2016, the first anniversary of the grant date.